Cargando…

Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis

Primary biliary cholangitis (PBC) is a chronic, cholestatic, immune-mediated, and progressive liver disorder. Treatment to preventing the disease from advancing into later and irreversible stages is still an unmet clinical need. Accordingly, we set up a drug repurposing framework to find potential t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahini, Endrit, Pasculli, Giuseppe, Mastropietro, Andrea, Stolfi, Paola, Tieri, Paolo, Vergni, Davide, Cozzolongo, Raffaele, Pesce, Francesco, Giannelli, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312896/
https://www.ncbi.nlm.nih.gov/pubmed/35884999
http://dx.doi.org/10.3390/biomedicines10071694
_version_ 1784753945657212928
author Shahini, Endrit
Pasculli, Giuseppe
Mastropietro, Andrea
Stolfi, Paola
Tieri, Paolo
Vergni, Davide
Cozzolongo, Raffaele
Pesce, Francesco
Giannelli, Gianluigi
author_facet Shahini, Endrit
Pasculli, Giuseppe
Mastropietro, Andrea
Stolfi, Paola
Tieri, Paolo
Vergni, Davide
Cozzolongo, Raffaele
Pesce, Francesco
Giannelli, Gianluigi
author_sort Shahini, Endrit
collection PubMed
description Primary biliary cholangitis (PBC) is a chronic, cholestatic, immune-mediated, and progressive liver disorder. Treatment to preventing the disease from advancing into later and irreversible stages is still an unmet clinical need. Accordingly, we set up a drug repurposing framework to find potential therapeutic agents targeting relevant pathways derived from an expanded pool of genes involved in different stages of PBC. Starting with updated human protein–protein interaction data and genes specifically involved in the early and late stages of PBC, a network medicine approach was used to provide a PBC “proximity” or “involvement” gene ranking using network diffusion algorithms and machine learning models. The top genes in the proximity ranking, when combined with the original PBC-related genes, resulted in a final dataset of the genes most involved in PBC disease. Finally, a drug repurposing strategy was implemented by mining and utilizing dedicated drug–gene interaction and druggable genome information knowledge bases (e.g., the DrugBank repository). We identified several potential drug candidates interacting with PBC pathways after performing an over-representation analysis on our initial 1121-seed gene list and the resulting disease-associated (algorithm-obtained) genes. The mechanism and potential therapeutic applications of such drugs were then thoroughly discussed, with a particular emphasis on different stages of PBC disease. We found that interleukin/EGFR/TNF-alpha inhibitors, branched-chain amino acids, geldanamycin, tauroursodeoxycholic acid, genistein, antioestrogens, curcumin, antineovascularisation agents, enzyme/protease inhibitors, and antirheumatic agents are promising drugs targeting distinct stages of PBC. We developed robust and transparent selection mechanisms for prioritizing already approved medicinal products or investigational products for repurposing based on recognized unmet medical needs in PBC, as well as solid preliminary data to achieve this goal.
format Online
Article
Text
id pubmed-9312896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93128962022-07-26 Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis Shahini, Endrit Pasculli, Giuseppe Mastropietro, Andrea Stolfi, Paola Tieri, Paolo Vergni, Davide Cozzolongo, Raffaele Pesce, Francesco Giannelli, Gianluigi Biomedicines Article Primary biliary cholangitis (PBC) is a chronic, cholestatic, immune-mediated, and progressive liver disorder. Treatment to preventing the disease from advancing into later and irreversible stages is still an unmet clinical need. Accordingly, we set up a drug repurposing framework to find potential therapeutic agents targeting relevant pathways derived from an expanded pool of genes involved in different stages of PBC. Starting with updated human protein–protein interaction data and genes specifically involved in the early and late stages of PBC, a network medicine approach was used to provide a PBC “proximity” or “involvement” gene ranking using network diffusion algorithms and machine learning models. The top genes in the proximity ranking, when combined with the original PBC-related genes, resulted in a final dataset of the genes most involved in PBC disease. Finally, a drug repurposing strategy was implemented by mining and utilizing dedicated drug–gene interaction and druggable genome information knowledge bases (e.g., the DrugBank repository). We identified several potential drug candidates interacting with PBC pathways after performing an over-representation analysis on our initial 1121-seed gene list and the resulting disease-associated (algorithm-obtained) genes. The mechanism and potential therapeutic applications of such drugs were then thoroughly discussed, with a particular emphasis on different stages of PBC disease. We found that interleukin/EGFR/TNF-alpha inhibitors, branched-chain amino acids, geldanamycin, tauroursodeoxycholic acid, genistein, antioestrogens, curcumin, antineovascularisation agents, enzyme/protease inhibitors, and antirheumatic agents are promising drugs targeting distinct stages of PBC. We developed robust and transparent selection mechanisms for prioritizing already approved medicinal products or investigational products for repurposing based on recognized unmet medical needs in PBC, as well as solid preliminary data to achieve this goal. MDPI 2022-07-13 /pmc/articles/PMC9312896/ /pubmed/35884999 http://dx.doi.org/10.3390/biomedicines10071694 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shahini, Endrit
Pasculli, Giuseppe
Mastropietro, Andrea
Stolfi, Paola
Tieri, Paolo
Vergni, Davide
Cozzolongo, Raffaele
Pesce, Francesco
Giannelli, Gianluigi
Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
title Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
title_full Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
title_fullStr Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
title_full_unstemmed Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
title_short Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
title_sort network proximity-based drug repurposing strategy for early and late stages of primary biliary cholangitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312896/
https://www.ncbi.nlm.nih.gov/pubmed/35884999
http://dx.doi.org/10.3390/biomedicines10071694
work_keys_str_mv AT shahiniendrit networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT pasculligiuseppe networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT mastropietroandrea networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT stolfipaola networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT tieripaolo networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT vergnidavide networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT cozzolongoraffaele networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT pescefrancesco networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis
AT giannelligianluigi networkproximitybaseddrugrepurposingstrategyforearlyandlatestagesofprimarybiliarycholangitis